Oncologists should ask in advance about what young patients and their parents want to be told about changing prognoses, a new ...

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

Medicaid is the main healthcare coverage for people living with HIV in the United States, according to data compiled by KFF.

New research shows that Medicaid expansion was linked to a 2.1% increase in timely lung cancer surgeries and a 2.8% rise in ...

A trial found magnetic resonance imaging correlated with physical function tests in patients with Duchenne muscular dystrophy ...

With policymakers considering work requirements for Medicaid eligibility, Jennifer Haley, principal research associate in the ...

The difference between specialty drugs and traditional drugs and how each have vied for market competition, according to Jeff ...

A panelist discusses how type 1 diabetes (T1D) is frequently misdiagnosed in adults due to its overlapping clinical features with type 2 diabetes (T2D), resulting in inappropriate treatment strategies ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The analysis from the Urban Institute breaks down projected coverage losses across the 40 Medicaid expansion states, where ...

A phase 1b showed promising results in lowering LDL in patients with heterozygous familial hypercholesterolemia and/or ...

In this first part of a two-part video series, Jennifer Haley, principal research associate of the Health Policy Division at ...